Patent details
LUC00204 Product Name: Fedratinib, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate thereof, in particular fedratinib dihydrochloride monohydrate
Basic Information
- Publication number:
- LUC00204
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP068365832
- Legal Status:
- Inactive
- Application number:
- LUC00204
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/20/1514
- Marketing Authorization Type:
- Marketing Authorization Date:
- 09/02/2021
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 10/05/2021
- First Marketing Authorization date:
- 09/02/2021
- Grant date:
- 20/09/2022
- Activation date:
- Publication date:
- 10/05/2021
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 26/10/2031
- SPC Extension Expiration:
- 26/10/2031
- Rejection date:
- Withdrawal date:
Owner
- From:
- 10/05/2021
- Name:
- Impact Biomedicines, Inc.
- Address:
- 86 Morris Avenue, Summit, New Jersey 07901, United States (US)
Agent
- Name:
- Dennemeyer & Associates S.A.
- From:
- 10/05/2021
- Address:
- 55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2021/07
- Publication date:
- 03/06/2021
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2022/11
- Publication date:
- 04/10/2022
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 02/11/2026
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 10/05/2021 | Outgoing Correspondence | 1 |
| 10/05/2021 | Marketing authorization | 3 |
| 10/05/2021 | Summary of the product caracteristics | 32 |
| 10/05/2021 | General Document | 47 |
| 10/05/2021 | Marketing authorization | 4 |
| 10/05/2021 | Application Form | 5 |
| 10/05/2021 | Publication | 1 |
| 20/09/2022 | Publication | 1 |
| 20/09/2022 | Certificate | 1 |
| 21/09/2022 | Outgoing Correspondence | 1 |